Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Oncosec Medical (NQ: ONCS)
2.120 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 9:06 AM EDT, Oct 18, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 15
Open 2.120
Bid (Size) 2.130 (1)
Ask (Size) 2.290 (1)
Prev. Close 2.120
Today's Range 2.120 - 2.120
52wk Range 0.3520 - 5.270
Shares Outstanding 52,344,611
Dividend Yield N/A
Performance
YTD
+223.66%
+223.66%
1 Month
-7.42%
-7.42%
3 Month
-15.20%
-15.20%
6 Month
+270.24%
+270.24%
1 Year
+34.18%
+34.18%
Top News
More News
OncoSec Announces New Peer-Reviewed Data for TAVO™ in Virus-Associated Skin Cancer Published in Clinical Cancer Research
OncoSec Medical Incorporated ("OncoSec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced the publication of new data in Clinical Cancer Research... Read More
from PR Newswire
OncoSec Announces $30 Million USD Strategic Investment at a Premium to Market by China Grand Pharmaceutical and Healthcare Holdings (CGP) in Connection with Exclusive License to TAVO™ in Greater China
CGP Obtains a 12-Month Option to Offer to Acquire the Remaining Shares of OncoSec at the Greater of $4.50 Per Share or 110% of the Market Price Read More
from PR Newswire
More News
Read More
OncoSec to Present at the Cantor 2019 Global Healthcare Conference
from PR Newswire
OncoSec to Present at the Ladenburg Thalmann 2019 Healthcare Conference
from PR Newswire
OncoSec to Present at the 21st Annual H.C. Wainwright Global Investment Conference
from PR Newswire
OncoSec Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Application with Claims Covering Cytokine-Based Intratumoral Immunotherapies
from PR Newswire
A Look At Benzinga Pro's Most-Searched Tickers For October 11, 2019
category SES , ROKU , News , and 13 more.
from Benzinga
Week in Review: Jiangsu's CTFH Signs $200 Million AI Drug Discovery Pact with Insilico
from ChinaBio® Today
CORRECTED-BRIEF-Oncosec says China Grand Pharmaceutical And Healthcare Holdings to invest $30 Mln in Co
category companyNews
from Reuters: Company News
China Grand Pharma Pays $30 Million for Majority Stake in US-Based OncoSec
from ChinaBio® Today
38 Stocks Moving In Friday's Mid-Day Session
category FRO , CATB , AU , and 50 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.